Wednesday, 16 May 2007

US panel: MedImmune's FluMist works for young kids

(Reuters) - MedImmune is seeking wider approval for a new version of the vaccine, which is already cleared for use in those ages 5 to 49 years old.




Read more at Reuters.com Government Filings News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)